Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warm Bupivacaine for eye block
NCT07085481Completed
- Sponsor
- Mansoura University
- Start
- Oct 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in cataract (2 arms), sponsored by Mansoura University. Primary endpoint: Time to onset of sensory block. Started Oct 2025; status: completed.
02
Drugs
bupivacaine
03
Conditions
cataract
Beyond the preview
Go deeper on NCT07085481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07085481.